Revian Announces Poster Presentation at 2024 Society for Investigative Dermatology Annual Meeting
Late breaking poster presentation highlights Revian’s patented combination of wavelengths has been shown to reduce Dihydrotestosterone production by 74% Morrisville, N.C., May 14, 2024 – REVIAN Inc., an aesthetic medical